Vaccine Dreams

Vaccine Dreams GE and NovaVax team up to create a portable vaccine factory that is faster, cheaper By Brendan Borrell Related Articles Bringing Good Things To Life (Science)? Gee Whiz, that's GE! Seeing faster, seeing smarter Slideshow: GE lights up life science Each year, a new strain of seasonal influenza is born in Southeast Asia and sweeps across the globe to North America and Europe, infecting between 3 million and 4 million people annual

Written byBrendan Borrell
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

By Brendan Borrell

Bringing Good Things To Life (Science)?

Gee Whiz, that's GE!

Seeing faster, seeing smarter

Slideshow: GE lights up life science

Each year, a new strain of seasonal influenza is born in Southeast Asia and sweeps across the globe to North America and Europe, infecting between 3 million and 4 million people annually before burning out somewhere in South America. World Health Organization (WHO) workers collect samples from flu sufferers in more than 80 countries to monitor current strains and to predict the strain that will become the year's killer. They are often wrong, however, and vaccine manufacturers can't simply whip up a new batch.

The lag time between identifying the breakout strain, manufacturing the vaccine, and distributing it to where it's needed can take six to nine months. With seasonal flu, those who fall ill may lose a few days of work, but H5N1 avian flu is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies